Adia Nutrition, Inc. 2026: Revenue $485.39K, Net income $40.42K, EPS $0— 10-Q Summary
ADIA
Adia Nutrition, Inc. reported results for the 2026 period with revenue of $485.39K and net income of $40.42K, a swing from a loss in the prior-year period; diluted EPS was $0 for both periods — 10-Q Summary
| Metric | Current quarter | Prior year quarter | YoY change |
| Revenue¹ | $485.39K | $118.15K | 310.8% |
| Net income² | $40.42K | ($124K) | 132.6% |
| Diluted EPS³ | $0 | $0 | — |
¹ Reported as “Total Revenue”. ² Reported as “Net Income (Loss)”. ³ Reported as “Net Income (Loss) Per Share: Diluted”
Business Highlights
- Revenue growth: Six-month revenue rose to $661.66K from $189.91K in the prior year, reflecting strong top-line momentum.
- Channel shift: Medical procedures became the primary revenue driver, accounting for 65.7% of H1 2026 revenue, while supplement sales declined to zero.
- Product mix and margins: Increased biologics sales and procedure revenue helped gross profit improve to $350,157 for H1 2026.
- Operational expansion: The company increased operating activities, including higher salaries, clinical trial fees and corporate/PR expenses to support growth.
- Near-term outlook: Management expects operating costs of $450K–$750K and plans to use its line of credit and other funding sources as needed to support continued growth.
Original SEC Filing:Adia Nutrition, Inc. [ ADIA ] – 10-Q – Aug. 13, 2026
DisclaimerThis is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.
EarningsTradingViewUS stocks
